Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids

Dermatologic Surgery

Volumn 31, Issue 10, 2005, Pages 1297-1303

  Carruthers, Alastair ^a   Carruthers, Jean ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CAPILLARY RESISTANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EYEBROW HEAVINESS; EYELID MUSCLE; FACE MALFORMATION; GLABELLAR RHYTID; HEADACHE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MUSCLE CONTRACTILITY; MUSCLE MASS; MUSCLE SPASM; MUSCLE TWITCH; PARALLEL DESIGN; PATIENT SATISFACTION; PHYSICAL ATTRACTIVENESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SELF CONCEPT; SELF EVALUATION; TIC;

EID: 27744432912     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200510000-00006     Document Type: Article

References (4)

1. Botox Cosmetic (botulinum toxin type A) purified neurotoxin complex [package insert], Irvine (CA): Allergan, Inc.; 2004.
2. Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840-9.
3. Carruthers JD, Lowe NJ, Menter MA, et al, for the Botox Glabellar Lines II Study Group. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 2003;112:1089-98.
4. Carruthers A, Carruthers J, Said S. Double-blind, randomized, parallel group, dose-ranging study of botulinum toxin type A (BOTOX®, Allergan, Inc.) in the treatment of glabellar lines. Poster presented at the European Academy of Dermatology and Venereology; 2001 Oct 10; Munich, Germany.